In vivo investigation of NF-κB inhibition in acidic bile-treated hypopharyngeal mucosa, supported by future global molecular sequencing analysis, may provide insights into the effective prevention of the induced premalignant phenotype and deregulated oncogenic signaling pathways, previously linked to HNSCC [36]. This evidence concerns the gene NFKB1 and head and neck squamous cell carcinoma.